Consumer tech-focused Foresight Acquisition II in a letter to the SEC said it is withdrawing an offering of 20 million units. The SPAC initially registered 25 million units with the regulator in June 2021, downsizing to 20 million last October.
Foresight II had planned to target companies in the technology-enabled consumer and consumer healthcare industries.
Management’s first SPAC, Foresight I, raised $316.25 million in a February 2021 IPO and closed a merger with P3 Health Partners last December.
The CEO of both Foresight SPACs, Michael Balkin, was a partner and formerly co-manager of the William Blair small institutional portfolio and the William Blair small cap growth fund.
Foresight II had planned to list on the Nasdaq with Cown and William Blair tapped as co-bookrunning managers. Read more.
